Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants

In response to the fast-waning immune response and the great threat of the Omicron variant of concern (VOC) to the public, we report the pilot-scale production of an inactivated Omicron vaccine candidate that induces high levels of neutralizing antibody titers to protect against the Omicron virus. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuntao, Tan, Wenjie, Lou, Zhiyong, Zhao, Yuxiu, Zhang, Jin, Liang, Hongyang, Li, Na, Zhu, Xiujuan, Ding, Ling, Huang, Baoying, Zhou, Weimin, Guo, Yancen, Yang, Zhaona, Qiao, Yuling, He, Zhenyu, Ma, Bo, He, Yao, Zhu, Di, Wang, Zhanhui, Chang, Zhen, Zhao, Xue, Wang, Wei, Xu, Ying, Zhu, Huiqin, Zheng, Xiaotong, Wang, Chenlong, Xu, Guangxue, Wu, Guizhen, Wang, Hui, Yang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318641/
https://www.ncbi.nlm.nih.gov/pubmed/35891313
http://dx.doi.org/10.3390/vaccines10071149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318641/
https://www.ncbi.nlm.nih.gov/pubmed/35891313
http://dx.doi.org/10.3390/vaccines10071149

Ejemplares similares